Skip to contentClarengateINTELLIGENCE
Companies/14344385

Case45 Ltd

Research and experimental development on biotechnology · London

ActiveUnited KingdomIncorporated 2022Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2025-09-30

IXBRL · 113 source facts · 20 selected values

Validation findings
XBRL valid
Reporting period
2024-10-01 to 2025-09-30
Extraction status
complete
Numeric facts
68
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2025-01-01.xsd
Currency
GBP
Source identifier
Prod224_2512_14344385_20250930
Source archive
Accounts_Monthly_Data-December2025.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2024-09-30

IXBRL · 97 source facts · 20 selected values

Not assessed
legacy record
Reporting period
2023-10-01 to 2024-09-30
Extraction status
Legacy / not assessed
Numeric facts
52
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_3100_14344385_20240930
Source archive
Accounts_Monthly_Data-November2024.zip

Accounts to 2023-09-30

IXBRL · 63 source facts · 6 selected values

Not assessed
legacy record
Reporting period
2022-09-08 to 2023-09-30
Extraction status
Legacy / not assessed
Numeric facts
17
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_0033_14344385_20230930
Source archive
Accounts_Monthly_Data-November2023.zip

Registered details

14344385
Status
Active
Type
Private Limited Company
Incorporated
2022-09-08
Jurisdiction
—
Registered office
5 BEACONSFIELD ST, KING'S CROSS, LONDON, N1C 4EW, UNITED KINGDOM

Classification

2 SIC codes
7211072190

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

1 matched grants
Guiding treatment decisions in breast cancer with artificial intelligenceLead
Innovate UK · Collaborative R&D · 2023-11-01 – 2024-10-31 · with 1 other participant
£225,685
awarded